Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Medical Necessity Criteria for Noninvasive Prenatal Testing

Introduction to NIPT Guidelines

  • The American College of Medical Genetics and Genomics (ACMG) strongly recommends noninvasive prenatal testing (NIPT) using cell-free fetal nucleic acids in maternal blood for screening for fetal aneuploidy (trisomy 13, 18, 21, and sex chromosome aneuploidy) for all pregnant women, regardless of risk status 1, 2

Evidence Supporting Medical Necessity

  • NIPT for trisomy 21 (Down syndrome) shows a detection rate of 98.8% with a false-positive rate of only 0.04%, significantly outperforming traditional screening methods 3, 4
  • For trisomy 18, NIPT demonstrates 98.83% sensitivity and 0.07% false-positive rate 3, 4
  • For trisomy 13, NIPT shows 92.85% sensitivity and 0.04% false-positive rate 3, 4
  • For sex chromosome aneuploidies, NIPT has an overall detection rate of 99.6% with 99.8% specificity 5, 6

Medical Necessity Criteria

  • The American College of Medical Genetics and Genomics (ACMG) establishes medical necessity for NIPT (CPT code 81420) for all pregnant women with singleton pregnancies, regardless of maternal age or risk status 2, 3
  • The ACMG also establishes medical necessity for NIPT for all pregnant women with twin pregnancies 7, 5
  • NIPT for twins shows equivalent screening characteristics to singleton pregnancies for trisomy 21 (98.2% sensitivity) 6
  • For trisomy 18 and 13 in twins, sensitivities are 90% and 80% respectively 4

Screening for Sex Chromosome Aneuploidies

  • The ACMG recommends screening for sex chromosome aneuploidies in singleton pregnancies, including conditions like Turner syndrome (45,X), Triple X syndrome (47,XXX), Klinefelter syndrome (47,XXY), and 47,XYY syndrome 5, 6

Clinical Considerations and Limitations

  • The ACMG advises that NIPT should not be performed in pregnancies with known vanishing twin, as this may affect accuracy of results 1, 8
  • Known maternal malignancy is a relative contraindication due to potential somatic genomic aberrations 1, 8

Common Pitfalls to Avoid

  • Failing to recognize that NIPT has superior detection rates compared to traditional screening methods for all pregnant women, not just those at high risk 2, 3
  • Not understanding that NIPT for sex chromosome abnormalities has varying positive predictive values (PPVs): 29.5% for 45,X, 54% for XXX, 74% for XXY, and 74.5% for XYY 5, 6
  • Overlooking the need for appropriate pre-test and post-test genetic counseling, especially when screening for sex chromosome abnormalities 5, 6

REFERENCES